Global companies investing in the United States face unique opportunities and challenges. Doing business in the US reviews the key tax issues and provides insights to help investors navigate the US business environment. Read more
Our July edition features final Section 108 regulations, temporary and proposed regulations, and private letter rulings
This Alert provides an update to those FASB projects that will impact accounting or disclosures related to income taxes that may be of interest to companies in the Pharmaceutical and Life Sciences sector.
The FASB’s proposed income tax disclosure framework would require additional disclosure for all entities.
Global companies investing in the United States face unique opportunities and challenges. Doing business in the US reviews the key tax issues and provides insights to help investors navigate the US business environment.
This publication is designed to help multinationals stay aware of tax accounting and regulatory developments under US GAAP and IFRS, while providing technical guidance on challenging tax accounting areas. This edition features significant tax law changes around the globe, key aspects of income tax accounting under IFRS and US GAAP for foreign currency movements and transactions, and more.
In this recorded webcast, a panel of our Tax Accounting Services specialists discuss tax accounting matters including an update on the tax impacts of the revenue recognition standard, recent activity from standard setters, and other relevant ASC 740 topics and considerations.
In this edition of Rx Marketplace Quarterly, we discuss the most recent quarter's industry IPOs, venture capital funding, and M&A activity.
New proposed regulations provide additional clarity and flexibility for deferred compensation plans.
Join one of our upcoming trainings to earn up to 18.5 CPE credits, and develop the ability to understand the requirements of Accounting for Income Taxes, including income statement, balance sheet calculations and much more.
This alert highlights the ways in which the new proposed regulations under Section 385 will affect real estate funds and REITs.